

Massar
99 posts

@MassarOmard
Danish MD, postdoc at #Mayoclinic, Department of #Cardiology. Collecting my jar of a good living life.









Do we have a new option in the treatment of #CardShock related to #AMI? Past ACVC President @CHassager together with Prof. Jacob E Moeller just published the long awaited results of the DanGer Shock trial #ACC24 ⬇️ mortality #MCS vs standard care alone nejm.org/doi/full/10.10…









#OriginalResearch: Insights on hemodynamic effects of SGLT2 inhibitors in #HFpEF by @bborlaugmd et al.: Dapagliflozin reduces resting and exercise PCWP @rickey_carter @yreddyhf @Massaromard @dejanapopovic ahajournals.org/doi/10.1161/CI… @bborlaugmd








"The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEF" jacc.org/doi/epdf/10.10… Working up appetite for the results of the STEP-HFpEF trials! clinicaltrials.gov/study/NCT05371… clinicaltrials.gov/study/NCT04916…








Empire Prevent 🩵🩷 includes patients in Odense @CardResearchOuh and Copenhagen @HGHHjerte. We greatly appreciate our collaboration with @SDCOdense and @RigsHeart 🩵🩷

Huge congrats to Prof. Jacob Eifer Møller with the @novonordiskfond Clinical Distinguished Investigator 2023 - and the DKK 10 mio that follows! 🎉 Jacob receives the award for his research with mechanical circulatory support in cardiogenic shock. @OUHhospital @RigsHeart

I would say this paper is probably a game changer due to the explanation of the absence of neurohormonal antagonists and by raising new hypothesis for future HFPEF trials. @GianluSava @mewton_nathan @ARakisheva @m_piepoli @cardioceptor @BiykemB @WilfriedMullens @MarcoMetra